Jw Holdings (096760) - Total Liabilities
Based on the latest financial reports, Jw Holdings (096760) has total liabilities worth ₩662.18 Billion KRW (≈ $448.75 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jw Holdings - Total Liabilities Trend (2007–2024)
This chart illustrates how Jw Holdings's total liabilities have evolved over time, based on quarterly financial data. See Jw Holdings (096760) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Jw Holdings Competitors by Total Liabilities
The table below lists competitors of Jw Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mediantechn
PA:ALMDT
|
France | €71.02 Million |
|
ADF Group Inc.
TO:DRX
|
Canada | CA$150.82 Million |
|
PChome Online
TWO:8044
|
Taiwan | NT$24.18 Billion |
|
Osisko Metals Inc
V:OM
|
Canada | CA$83.54 Million |
|
INKEVERSE GROUP DL-001
F:5IK
|
Germany | €735.62 Million |
|
Hi-Clearance
TWO:1788
|
Taiwan | NT$2.03 Billion |
|
Kaap Agri Bedryf Employee and Farm Worker Bee Trust
JSE:KAL
|
South Africa | ZAC4.59 Billion |
|
Bahvest Resources Bhd
KLSE:0098
|
Malaysia | RM37.68 Million |
Liability Composition Analysis (2007–2024)
This chart breaks down Jw Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jw Holdings market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jw Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jw Holdings (2007–2024)
The table below shows the annual total liabilities of Jw Holdings from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩729.21 Billion ≈ $494.18 Million |
-11.88% |
| 2023-12-31 | ₩827.51 Billion ≈ $560.79 Million |
+0.39% |
| 2022-12-31 | ₩824.32 Billion ≈ $558.63 Million |
+8.33% |
| 2021-12-31 | ₩760.96 Billion ≈ $515.69 Million |
-2.91% |
| 2020-12-31 | ₩783.76 Billion ≈ $531.14 Million |
-12.12% |
| 2019-12-31 | ₩891.84 Billion ≈ $604.39 Million |
+1.97% |
| 2018-12-31 | ₩874.64 Billion ≈ $592.73 Million |
-10.44% |
| 2017-12-31 | ₩976.65 Billion ≈ $661.86 Million |
+6.27% |
| 2016-12-31 | ₩919.04 Billion ≈ $622.82 Million |
+13.10% |
| 2015-12-31 | ₩812.56 Billion ≈ $550.66 Million |
-1.40% |
| 2014-12-31 | ₩824.06 Billion ≈ $558.46 Million |
+5.86% |
| 2013-12-31 | ₩778.42 Billion ≈ $527.52 Million |
-10.70% |
| 2012-12-31 | ₩871.67 Billion ≈ $590.72 Million |
+2.77% |
| 2011-12-31 | ₩848.16 Billion ≈ $574.79 Million |
+55.79% |
| 2010-12-31 | ₩544.41 Billion ≈ $368.94 Million |
+11.28% |
| 2009-12-31 | ₩489.21 Billion ≈ $331.53 Million |
+14.27% |
| 2008-12-31 | ₩428.10 Billion ≈ $290.12 Million |
+25.85% |
| 2007-12-31 | ₩340.17 Billion ≈ $230.53 Million |
-- |
About Jw Holdings
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more